Markets:

Overview

News

Currencies

International

Treasuries

Organon & Co. Common Stock (NY:OGN)

7.390 +0.330 (+4.67%)

Official Closing Price Updated: 7:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Organon & Co. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Unpacking Q4 Earnings: Pfizer (NYSE:PFE) In The Context Of Other Branded Pharmaceuticals Stocks

March 27, 2025

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the branded pharmaceuticals industry, including Pfizer (NYSE:PFE) and its peers.

Via StockStory

Topics Artificial Intelligence Intellectual Property

3 Small-Cap Stocks Skating on Thin Ice

March 26, 2025

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a...

Via StockStory

1 Healthcare Stock with Solid Fundamentals and 2 to Turn Down

March 21, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But financial performance has lagged recently as players offloaded surplus COVID...

Via StockStory

Topics Stocks

Earnings Scheduled For February 13, 2025 ↗

February 13, 2025

Via Benzinga

Looking Into Organon's Recent Short Interest ↗

November 07, 2024

Via Benzinga

P/E Ratio Insights for Organon ↗

October 02, 2024

Via Benzinga

3 Cheap High Dividend Stocks For Passive Income ↗

August 30, 2024

These undervalued high yield stocks could return over 10% per year.

Via Talk Markets

Q4 Earnings Highs And Lows: Royalty Pharma (NASDAQ:RPRX) Vs The Rest Of The Branded Pharmaceuticals Stocks

March 21, 2025

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Royalty Pharma (NASDAQ:RPRX)...

Via StockStory

Topics Artificial Intelligence Intellectual Property

Q4 Earnings Outperformers: Corcept (NASDAQ:CORT) And The Rest Of The Branded Pharmaceuticals Stocks

March 04, 2025

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the branded pharmaceuticals industry, including Corcept (NASDAQ:CORT) and its peers.

Via StockStory

Topics Artificial Intelligence Intellectual Property

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields ↗

February 19, 2025

Via Benzinga

High-Yield Healthcare: 3 Stocks With Strong Dividends

February 16, 2025

This article covers three healthcare stocks that offer dividend yields of at least 7% and dives deeper into the fundamentals to determine if they're good buys.

Via MarketBeat

High Dividend 50: Organon & Co. ↗

June 27, 2024

Organon & Co.’s current annual dividend is $1.12 per share. At around $20 per share, Organon stock has a high yield of 5.4%.

Via Talk Markets

Organon (OGN) Shares Skyrocket, What You Need To Know

February 13, 2025

Shares of pharmaceutical company Organon (NYSE:OGN) jumped 12.5% in the morning session after the company reported fourth-quarter 2024 results that topped analysts' revenue and EPS expectations. While...

Via StockStory

Topics Initial Public Offering

Organon (NYSE:OGN) Exceeds Q4 Expectations But Full-Year Sales Guidance Misses Expectations Significantly

February 13, 2025

Pharmaceutical company Organon (NYSE:OGN) reported Q4 CY2024 results exceeding the market’s revenue expectations, but sales were flat year on year at $1.59 billion. On the other hand, the company’s...

Via StockStory

Organon (OGN) Q4 Earnings Report Preview: What To Look For

February 12, 2025

Pharmaceutical company Organon (NYSE:OGN) will be reporting earnings tomorrow before market hours. Here’s what investors should know.

Via StockStory

Want $2,000 in Annual Dividends? Invest $11,000 in Each of These 3 Stocks. ↗

January 01, 2025

Via The Motley Fool

Want $300 in Dividends Every Month? Invest $20,000 in Each of These 3 Stocks ↗

October 24, 2024

These dividend stocks all pay yields of around 6% and higher.

Via The Motley Fool

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q4 ↗

October 22, 2024

Via Benzinga

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields ↗

October 21, 2024

Via Benzinga

Organon, Howmet Aerospace And More: CNBC's 'Final Trades' ↗

October 03, 2024

On CNBC's "Halftime Report Final Trades," Stephen Weiss of Short Hills Capital Partners named ProShares Short QQQ as his final trade.

Via Benzinga

Week In Review: Nippon Shinyaku Signs $735 Million Deal For DMD Therapy ↗

September 21, 2024

Japan’s Nippon Shinyaku will acquire European rights for a Duchenne muscular dystrophy disease therapy developed by Capricor Therapeutics of San Diego. Nippon Shinyaku will pay $20 million upfront and...

Via Talk Markets

Roivant Sciences Offloads Psoriasis Medicine Maker To Organon For Up To $1.2B ↗

September 18, 2024

Organon is set to acquire Roivant Sciences' Dermavant Sciences, known for developing immuno-dermatology treatments, including FDA-approved Vtama cream for plaque psoriasis. The deal, valued up to $1.2...

Via Benzinga

JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability ↗

September 06, 2024

JP Morgan assesses the specialty pharma sector, highlighting robust fundamentals and new product excitement. Key focus on Teva, Organon, and Viatris.

Via Benzinga

Organon Stock Sees Relative Strength Rating Rise To 91 ↗

August 27, 2024

On Tuesday, Organon[ stock hit an key technical milestone, seeing its Relative Strength Rating jump to 91, up from 88 the day before.

Via Investor's Business Daily

Organon Stock Earns Relative Strength Rating Upgrade; Hits Key Threshold ↗

August 20, 2024

On Tuesday, generic drug maker Organon stock had its Relative Strength (RS) Rating upgraded to 83, up from 78 a day earlier.

Via Investor's Business Daily

OGN Stock Earnings: Organon Beats EPS, Misses Revenue for Q2 2024 ↗

August 06, 2024

OGN stock results show that Organon beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

Via InvestorPlace

Jim Cramer Says No To This Health Care Stock, Recommends Holding On To Constellation Energy: 'It's Up A Huge Amount' ↗

July 30, 2024

Jim Cramer said Constellation Energy is a "solar play that is a very good company. It's up a huge amount versus a lot of other stocks."

Via Benzinga

3 High-Yield Dividend ETFs to Buy to Generate Passive Income ↗

July 06, 2024

These exchange-traded funds should keep the income flowing in regularly.

Via The Motley Fool

Topics ETFs

Value Investing Is Back! 3 Stocks With Strong Fundamentals to Buy Now ↗

June 26, 2024

Uncover three top value stocks to buy with robust fundamentals for stable long-term growth amid turbulence.

Via InvestorPlace

3 Stocks With Mouthwatering Dividends You Can Buy Right Now ↗

June 08, 2024

These stocks offer great dividends and more.

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Organon & Co. Common Stock (NY:OGN)

Headline News about Organon & Co. Common Stock

Starting at $3.75/week.

Subscribe Today